Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Due this week

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Nov 18, 2021 7:19pm

123 Views

Post# 34143370

RE:Due this week

It looks like we achieved one item only on the list for this week. The rest are due already so next week possibly

- Reduvo passed 180 days with health Canada and din is due
- QIXLEEF interim for reborn
- QIXLEEF interim for plenitude
- QIXLEEF eu approval for orphan drug by end of the week. This is received. I think tetra will follow you with an official drug submission. Not sure when

Most of these are late. I'm not sure if guy want to sequence them in a short time window so is delaying some of it.

sp is at a very attractive level ahead of major milestones which is really surprising but whatever. If it pours gold put the bucket out

gl longs

[/quote]

<< Previous

Bullboard Posts

Next >>

Red Light Holland and PharmAla notch psilocybin extraction